Pancreatic cancer research, clinical trials supported with $10.9 million NCI grant

October 18, 2023October 18, 2023

Researchers at Washington University School of Medicine in St. Louis have received an NCI grant that will provide about $10.9 million to research programs for the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer. (Image: Getty Images)

Researchers receive prestigious SPORE grant for pancreatic cancer

Researchers at Washington University School of Medicine in St. Louis have received a prestigious Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support research and clinical trials aimed at improving therapies for pancreatic cancer.